Novartis Ag (NVS) Long-Term Investments (2009 - 2026)

Novartis Ag (NVS) has 13 years of Long-Term Investments data on file, last reported at -$24.0 million in Q1 2026.

• Quarterly Long-Term Investments fell 121.05% year-over-year to -$24.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$24.0 million (down 121.05% YoY) and the FY2025 annual result came in at $98.0 million, up 304.17% from the prior year.
• Long-Term Investments eased to -$24.0 million in Q1 2026 per NVS's latest filing, from $98.0 million in the prior quarter.
• The five-year high for Long-Term Investments was $205.0 million in Q4 2023, with the low at -$53.0 million in Q3 2024.
• Average Long-Term Investments over 5 years is $53.4 million, with a median of $85.0 million recorded in 2025.
• Year-over-year, Long-Term Investments surged 471.43% in 2023 and sank 126.24% in 2024.
• Novartis Ag's Long-Term Investments stood at $143.0 million in 2022, then surged by 43.36% to $205.0 million in 2023, then plunged by 123.41% to -$48.0 million in 2024, then soared by 304.17% to $98.0 million in 2025, then sank by 124.49% to -$24.0 million in 2026.
• Business Quant data shows NVS's Long-Term Investments at -$24.0 million in Q1 2026, $98.0 million in Q4 2025, and $85.0 million in Q3 2025.